Rockwell Medical affirms FY2026 sales guidance $70M–$75M
Rockwell Medical (NASDAQ: RMTI) affirms FY2026 sales guidance of $70.000M–$75.000M, unchanged, versus a $72.469M estimate.
Rockwell Medical (NASDAQ: RMTI ) affirms FY2026 sales outlook from $70.000 million-$75.000 million to $70.000 million-$75.000 million vs $72.469 million estimate.